Metraipolis › archive › dc_ddda9bc06c45

Immunotherapy With Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors in Patients With Advanced Non-Small Cell Lung Cancers: A… — Europe PMC PMID:41245885

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41245885
DOI: 10.1002/mco2.70476
License (as archived): solo-consultazione
Archived: 2026-11-08T13:49:15.900Z
SHA-256 of the archived text: 1b04986e8096ebfa41efcbc4078157fe0758c055fe2a4f8f5aa54032816a79ea
Stable URL of this page: https://metraipolis.com/documento/dc_ddda9bc06c45

How to cite

Immunotherapy With Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors in Patients With Advanced Non-Small Cell Lung Cancers: A… — Europe PMC PMID:41245885 — Europe PMC (en), https://europepmc.org/article/MED/41245885 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ddda9bc06c45 (Metraipolis archive dc_ddda9bc06c45, sha256 1b04986e8096ebfa41efcbc4078157fe0758c055fe2a4f8f5aa54032816a79ea)

BibTeX

@misc{dcddda9bc06c45,
  title = {Immunotherapy With Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors in Patients With Advanced Non-Small Cell Lung Cancers: A… — Europe PMC PMID:41245885},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41245885},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ddda9bc06c45; sha256 1b04986e8096ebfa41efcbc4078157fe0758c055fe2a4f8f5aa54032816a79ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41245885. Agents can read the archived copy with the MCP tool read_document.